Literature DB >> 24760956

Selective attention and facial expression recognition in patients with Parkinson's disease.

Laura Alonso-Recio1, Juan M Serrano2, Pilar Martín2.   

Abstract

Parkinson's disease (PD) has been associated with facial expression recognition difficulties. However, this impairment could be secondary to the one produced in other cognitive processes involved in recognition, such as selective attention. This study investigates the influence of two selective attention components (inhibition and visual search) on facial expression recognition in PD. We compared facial expression and non-emotional stimuli recognition abilities of 51 patients and 51 healthy controls, by means of an adapted Stroop task, and by "The Face in the Crowd" paradigm, which assess Inhibition and Visual Search abilities, respectively. Patients scored worse than controls in both tasks with facial expressions, but not with the other nonemotional stimuli, indicating specific emotional recognition impairment, not dependent on selective attention abilities. This should be taken into account in patients' neuropsychological assessment given the relevance of emotional facial expression for social communication in everyday settings.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Attention; Emotional processing; Executive function; Mild cognitive impairment; Movement disorder; Parkinson's disease

Mesh:

Year:  2014        PMID: 24760956     DOI: 10.1093/arclin/acu018

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  2 in total

1.  Deficits in Emotion Perception and Cognition in Patients with Parkinson's Disease: A Systematic Review.

Authors:  Mohit Gothwal; Shyam Sundar Arumugham; Ravi Yadav; Pramod K Pal; Shantala Hegde
Journal:  Ann Indian Acad Neurol       Date:  2022-04-06       Impact factor: 1.714

Review 2.  Facial emotion recognition in Parkinson's disease: A review and new hypotheses.

Authors:  Soizic Argaud; Marc Vérin; Paul Sauleau; Didier Grandjean
Journal:  Mov Disord       Date:  2018-02-23       Impact factor: 10.338

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.